SCHEMBL5514366

SCHEMBL5514366

Cc1cn(Cc2ccc(F)c(F)c2)c2ccc(F)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER3 P43115 6/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CACNB4 O00305 1/20 0.43
▸ CACNA1A O00555 1/20 0.43
▸ CACNA1G O43497 1/20 0.43
▸ CACNG3 O60359 1/20 0.43
▸ CACNA1F O60840 1/20 0.43
▸ CACNA1H O95180 1/20 0.43
▸ CACNB3 P54284 1/20 0.43
▸ CACNA2D1 P54289 1/20 0.43
▸ CACNG7 P62955 1/20 0.43
▸ CACNA1B Q00975 1/20 0.43
▸ CACNA1D Q01668 1/20 0.43
▸ CACNB1 Q02641 1/20 0.43
▸ CACNG1 Q06432 1/20 0.43
▸ CACNB2 Q08289 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29092883 0.82 HTR6 (0.53) MAPTPOLBMEN1KMT2ACACNB4
SCHEMBL26581664 0.82 SLC22A12 (0.50) PTGER3THRBTHRA
SCHEMBL1924422 0.77 PTGER3 (0.52) PTGER3
SCHEMBL24824798 0.77 CYP19A1 (0.44) GAAMAPT
SCHEMBL20787916 0.74 CACNB4 (0.51) GAAMAPTCACNB4CACNA1ACACNA1G
SCHEMBL1925953 0.74 PTGER3 (0.49) PTGER3CACNA1GCACNA1HCACNA1I
SCHEMBL1926098 0.73 PTGER3 (0.56) PTGER3MAPTTHRBTHRA
SCHEMBL12225809 0.73 POLB (0.63) MAPTPOLBMEN1KMT2ATP53
SCHEMBL25500049 0.73 ICMT (0.43) MAPTPOLBMEN1KMT2A
SCHEMBL18508845 0.72 ALDH1A1 (0.65) GAAMAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812426-A1 ARYL SULFONAMIDE PERI-SUBSTITUTED BICYCLICS FOR OCCLUSIVE ARTERY DISEASE Decode Genetics, Inc. (US) 2007-08-01 — — EP disclosed
WO-2006044405-A1 ARYL SULFONAMIDE PERI-SUBSTITUTED BICYCLICS FOR OCCLUSIVE ARTERY DISEASE DECODE GENETICS, INC. (US) 2006-04-27 — — WO disclosed
Send feedback